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About the electronic Persistent Pain Outcomes Collaboration (ePPOC)  
ePPOC is a program which aims to help improve services and outcomes for patients experiencing 
chronic pain through benchmarking of care and treatment. ePPOC is an initiative of the Faculty of 
Pain Medicine and has been further developed in recent years by the Faculty and the wider pain 
sector.  
ePPOC involves the collection of a standard set of data items and assessment tools by specialist pain 
services throughout Australia and New Zealand to measure outcomes for their patients as a result of 
treatment. This information is being used to develop an Australasian benchmarking system for the 
pain sector, which will lead to better outcomes and best practice interventions for patients 
experiencing chronic pain. The information will also enable development of a coordinated approach 
to research into the management of pain in Australasia.  
Participation in ePPOC is voluntary and aims to assist pain management service providers to improve 
practice. epiCentre (the software purpose-built for ePPOC) helps to achieve this by: 
 providing clinicians with an approach to systematically assess individual patient experiences; 
 defining a common clinical language to streamline communication between pain 
management providers; and 
 facilitating the routine collection of Australasian pain management data to drive quality 
improvement through reporting and benchmarking.  
The ePPOC team is located within the Australian Health Services Research Institute at the University 
of Wollongong. If you would like more information about ePPOC please visit our website at 
https://ahsri.uow.edu.au/eppoc, email us at eppoc@uow.edu.au, or phone (02) 4221 5058. 
 
 
 
 
 
 
 
 
Percent of patients making clinically significant improvements from referral to episode end 
Enterprise One 
Domain 
All services 
Patient reported Carer reported Patient reported Carer reported 
58.3 77.8 Paediatric quality of life     70.6     67.3 
60.0 60.0 Average pain     52.8     64.2 
38.5 45.5 Worst pain     38.8     44.6 
50.0 50.0 Trouble sleeping     37.1     37.0 
75.0 - Functional disability      58.6 - 
Note: reported for patients experiencing at least moderate symptoms. If there are less than 10 episode outcomes please interpret this table with caution. 
‘All services’ represents data collected by eight services 
 
Executive Summary for Enterprise One Pain Management Service 
Demographic information  Episode information and service provision 
       
 Enterprise 
One 
All 
services 
  Enterprise 
One 
All 
services 
Active patients 100 834  Episodes started 83 716  
Gender (female) 73.0% 68.9%  
 Days from referral to episode 
start (median) 
 55.5  56.0 
Average age (years) 12.7 12.6  
 Ave length of episode 
(lapsed days) 
286.1 260.6  
Aboriginal and/or Torres 
Strait Islander 
1.1% 4.4%  
 Ave hours of services provided 
per episode 
 12.3  14.8  
Area of highest disadvantage 8.0% 12.5%  Episodes ended 50 410  
Outside healthy weight range 50.0% 44.9%    
Patient profile at referral 
Enterprise One received 54 patient completed referral questionnaires in this period 
 
      
Assessment tool average 
scores (patient reported) 
Enterprise 
One 
All 
services 
 Carer reported Enterprise 
One 
All 
services 
Pain Severity   5.6   5.3  % patients using medication daily  54.5  51.3 
PedsQL – Sleep 32.5 33.7  % patients using opioid medication 
daily (excluding codeine) 
  7.3   2.6  
PedsQL – Psychosocial 49.6 51.7  
PedsQL – Physical 35.8 37.6  % patients experiencing pain >12 mths  66.7  65.0  
PedsQL – Total 44.6 46.7  Ave school days missed in last 2 weeks   5.1   3.9 
Functional Disability Inventory  27.0  27.2  Ave % carer work impairment due to 
child’s pain 
 35.6  38.2 
BAPQ Pain-related worry   16.9  15.8  
Patient and carer outcomes reported 
 
      
Number of outcomes reported 
Enterprise One All services 
This period Last report % change This period Last report % change 
Patient reported 
Pathway outcomes 13           17    -23.5 131          167    -21.6 
Episode outcomes 14           15     -6.7 124          151    -17.9 
Post-episode 5            6    -16.7 58           41     41.5 
Carer reported 
Pathway outcomes 10           13    -23.1 126          157    -19.7 
Episode outcomes 11           11      0.0 116          137    -15.3 
Post-episode 5            7    -28.6 58           42     38.1 
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Introduction 
ePPOC aims to assist services to improve the quality of the pain management they provide through the 
analysis and benchmarking of patient outcomes. In this report, data submitted for patients active during 
the period 1 July 2019 to 30 June 2020 are summarised to enable participating services to assess their 
performance and compare this with outcomes achieved by other services.   
This report is broken into three sections:  
 Section 1 provides a summary of the data and outcomes included in this report  
 Section 2 presents a more detailed analysis of the outcome measures  
 Section 3 provides descriptive analysis at each of the patient, episode and pathway data levels  
In each of the three sections, data and analyses for Enterprise One Pain Management Service are presented 
alongside those for All services for comparative purposes. This process of reporting and benchmarking 
against other services provides opportunities to understand the services that are provided to patients, the 
outcomes patients experience and also to generate research opportunities focused on demonstrating 
variations in practice and outcomes. 
The outcome measures included in this report were agreed upon by representatives of the paediatric pain 
sector. Although no benchmarks for these outcomes have been included in this report, these will be 
incorporated in future reports when the volume of data is large enough to enable their creation. The 
process of reporting and benchmarking against other services provides opportunities to understand the 
services that are provided to patients, the outcomes patients experience and also to generate research 
opportunities focused on demonstrating variations in practice and outcomes. 
Data in the tables in this report are determined by a data scoping method. This data scoping method 
defines what data are included and can vary from table to table. Patients in each of the time points are not 
necessarily the same. More information about data scoping can be found in Appendix A. 
In this report the term ‘carer’ is used to denote data items responded to by a parent or carer. 
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Section 1 — Summary of data and outcomes included in this report 
1.1 Data summary 
 
Data were received from a total of eight services who provided information on 834 patients.  
The services providing data for this report are:  
 The Children’s Hospital at Westmead 
 Children's Complex Pain Service, John Hunter Children's Hospital  
 Monash Children’s Hospital 
 Queensland Interdisciplinary Paediatric Persistent Pain Service  
 Royal Children's Hospital Children's Pain Management Clinic, Melbourne  
 St Vincent’s Private Hospital Brisbane 
 Sydney Children's Hospital Randwick Interdisciplinary Complex Pain Service  
 Women's and Children's Paediatric Chronic Pain Service 
 
Table 1 includes data for all patients, episodes, pathways and questionnaires that were active in the 
reporting period. The relationship between the different levels of information collected under ePPOC 
(patient, episode, pathway, service event and questionnaires) is shown in Appendix D.  
 
Table 1  Number of patients, episodes, pathways and questionnaires 
 Enterprise One All services 
Number of patients 100 834 
Number of episodes 102 850 
Number of pathways 73 643 
Number of patient questionnaires returned 79 716 
Number of carer questionnaires returned 77 704 
Number of carer impact questionnaires returned 53 452 
Number of group pathways 2 34 
Number of individual pathways 71 593 
Number of concurrent pathways 0 9 
Number of one-off pathways 0 7 
Response rate to patient questionnaires (%) 56.5 57.9 
Response rate to carer questionnaires (%) 54.3 56.6 
Response rate to carer impact questionnaires (%) 54.6 53.6 
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Enterprise One reported on:  
 109 referral questionnaires (54 patient, 55 carer) 
 4 questionnaires at the start of a pathway (2 patient, 2 carer) 
 26 questionnaires at the end of a pathway (14 patient, 12 carer), and  
 12 post episode questionnaires (6 patient, 6 carer).   
In comparison, All services reported on; 
 839 referral questionnaires (419 patient, 420 carer) 
 79 questionnaires at the start of a pathway (42 patient, 37 carer) 
 275 questionnaires at the end of a pathway (141 patient, 134 carer), and 
 120 post episode questionnaires (58 patient, 62 carer).   
Patients and carers in each of the four time points are not necessarily the same. Therefore post episode 
and pathway start and end scores are not necessarily representative of patients or carers who completed 
earlier ratings. This comment applies equally to the remaining tables in this report unless otherwise noted.  
Non-valid scales and subscales have been excluded from this table. See Appendix C for more information 
on the volume and proportion of missing responses.  
Further information on the assessment tools and subscales can be found in Section 2 of this report.  
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1.2 Patient reported and carer reported outcome measure summary 
Table 2 and Table 3 show patients’ and carers’ average scores across the assessment tools for all referral 
questionnaires received in the reporting period.   
Table 2  Average assessment scores at referral — patient reported 
Outcome measure† Enterprise One All services 
Young children n = 0 n = 2 
Pain severity - 4.9 
PedsQL – Sleep -  25.0 
 – Psychosocial -  37.5 
 – Physical -  37.5 
    Total -  37.5 
Children n = 17 n = 141 
Pain severity 4.8 5.1 
PedsQL – Sleep  39.1 35.4 
 – Psychosocial 49.1 54.1 
 – Physical 32.8 36.7 
    Total 43.3 48.1 
FDI 27.5 26.6 
Adolescents n = 37 n = 276 
Pain severity 6.0 5.5 
PedsQL – Sleep 29.4 32.9 
 – Psychosocial 49.8 50.6 
 – Physical 37.2 38.0 
    Total 45.2 46.1 
FDI 26.8 27.4 
BAPQ-S5 16.9 15.8 
All ages n = 54 n = 419 
Pain severity 5.6 5.3 
PedsQL – Sleep 32.5 33.7 
 – Psychosocial 49.6 51.7 
 – Physical 35.8 37.6 
    Total 44.6 46.7 
FDI 27.0 27.2 
BAPQ-S5 16.9 15.8 
† See Appendix C for information on item completion. 
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Table 3  Average assessment scores at referral — carer reported 
Outcome measure† Enterprise One All services 
Young children n = 0 n = 15 
Pain severity - 4.6 
PedsQL – Sleep -  38.3 
  – Psychosocial -  53.3 
 – Physical -  42.6 
    Total -  49.2 
Children n = 17 n = 141 
Pain severity 4.9 5.2 
PedsQL – Sleep 35.3 35.5 
 – Psychosocial 45.5 50.6 
 – Physical 29.8 33.3 
    Total 40.0 44.4 
Adolescents n = 38 n = 264 
Pain severity 5.8 5.7 
PedsQL – Sleep 29.9 29.0 
 – Psychosocial 46.2 46.8 
 – Physical 32.3 35.0 
    Total 41.3 42.6 
All ages n = 55 n = 420 
Pain severity 5.5 5.5 
PedsQL – Sleep 31.6 31.5 
 – Psychosocial 46.0 48.4 
 – Physical 31.5 34.7 
    Total 40.9 43.5 
BAP-PIQ n = 50 n = 388 
 – Depression 15.3 15.2 
 – Anxiety 9.8 9.7 
 – Catastrophising 10.6 10.4 
 – Self-blame/helplessness 13.6 13.1 
 – Partner relationship 11.2 11.0 
 – Leisure functioning 17.8 17.5 
 – Parental behaviour 26.7 27.6 
 – Parental strain 9.1 8.7 
† See Appendix C for information on item completion. 
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Section 2 — Outcome measures in detail 
Eight standardised assessment tools have been chosen to measure patient outcomes and the impact of the 
patient’s pain on the carer. In addition, pain frequency, time from referral to first contact, and medication 
and health service use have also been included as outcomes.  
Records must have valid start and end scores for the outcome measure to be included in the following 
tables, therefore records where the response is not stated have been excluded from the calculation of %s in 
this section. See Appendix C for information on the proportion of missing responses. 
2.1 Standard assessment tools 
The assessment tools used in ePPOC are:  
 Modified Brief Pain Inventory (BPI) (Pain severity) 
 Faces Pain Scale – Revised (Pain severity) 
 Paediatric Quality of Life Inventory (PedsQL)  
 Functional Disability Inventory (FDI)  
 Bath Adolescent Pain Questionnaire – Pain-related worry section (BAPQ-S5) 
 Bath Adolescent Pain – Parent Impact Questionnaire (BAP-PIQ) 
 Work Productivity and Impairment (WPAI) 
 CARRA Body Chart.  
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2.1.1 Profile of patients and carer at referral 
Figure 1  Pain severity at referral 
  
Figure 2  PedsQL total at referral, distribution 
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Figure 3  PedsQL Sleep item score at referral 
    
Table 4  PedsQL — Percent of patients with impaired health related quality of life at referral 
Impaired HRQOL Enterprise One All services 
Patient reported 90.4     89.2 
Carer reported 92.6     89.7 
 
Figure 4  FDI severity at referral 
 
Figure 5  BAPQ-S5 pain-related worries, score at referral 
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Figure 6  BAP-PIQ Depression, score at referral 
 
Figure 7  BAP-PIQ Anxiety, score at referral 
 
Figure 8  BAP-PIQ Child-related catastrophising, score at referral 
 
Figure 9  BAP-PIQ Self-blame and helplessness, score at referral 
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Figure 10 BAP-PIQ Partner relationship, score at referral 
 
Figure 11 BAP-PIQ Leisure functioning, score at referral 
 
Figure 12 BAP-PIQ Parental behaviour, score at referral 
 
Figure 13 BAP-PIQ Parental strain, score at referral 
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2.1.2 Change from pathway start to pathway end 
In addition to considering the entire episode of care, the outcomes for pathways within an episode are also 
of interest. Enterprise One received patient pathway start and end questionnaires for 13 pathways. Note 
that the number of patients may differ from those in Table 2 as other questionnaire types may be used as a 
proxy for pathway start and end questionnaires. The average change for patients completing the 
assessment tools at pathway start and pathway end is shown in Table 5.  
Table 5  Assessment tools — Change from pathway start to pathway end 
Assessment tool† 
Enterprise One All services 
Score 
at 
referral 
Average 
change 
Valid 
outcome 
number 
Valid 
outcome 
% 
Score 
at 
referral 
Average 
change 
Valid 
outcome 
number 
Valid 
outcome 
% 
Patient 
Pain severity (n=13, 131)*   
Worst pain 7.4     -1.7           13    100.0 7.5     -1.6          129     98.5 
Least pain 3.2     -1.4           13    100.0 3.5     -1.2          128     97.7 
Usual pain 5.9     -2.3           12     92.3 5.7     -1.8          126     96.2 
Pain now 5.3     -2.5           13    100.0 5.1     -1.7          128     97.7 
PedsQL (n=13, 131)*   
Sleep 25.0     19.2           13    100.0 30.6     12.9          126     96.2 
Physical 47.4     12.3           13    100.0 39.5     17.3          129     98.5 
Emotional 50.4     15.8           13    100.0 46.7     15.2          127     96.9 
Social 60.0     10.4           13    100.0 61.1      8.7          129     98.5 
School 52.7      3.8           13    100.0 47.6      9.1          128     97.7 
Total 51.9     10.8           13    100.0 47.5     13.2          129     98.5 
FDI  (n=13, 131)* 24.6     -9.3           13    100.0 26.0     -8.9          128     97.7 
BAPQ-S5 (n=11, 81)* 15.3     -5.4           11    100.0 16.2     -4.9           80     98.8 
Carer 
Pain severity (n= 10, 126)*   
Worst pain 7.2     -1.7           10    100.0 7.5     -2.0          118     93.7 
Least pain 4.1     -1.4           10    100.0 3.6     -1.4          120     95.2 
Usual pain 6.2     -2.0           10    100.0 5.9     -2.0          120     95.2 
Pain now 5.5     -2.8           10    100.0 5.3     -2.0          121     96.0 
PedsQL (n=10, 126)*   
Sleep 22.5     27.8            9     90.0 32.5     16.2          119     94.4 
Physical 44.4     10.4           10    100.0 37.5     17.9          123     97.6 
Emotional 48.0     15.0            9     90.0 46.6     11.0          120     95.2 
Social 57.0     14.5           10    100.0 54.9     12.9          121     96.0 
School 46.0      9.5           10    100.0 46.6     12.8          122     96.8 
Total 48.3     11.8           10    100.0 45.2     14.1          122     96.8 
† See Appendix C for information on item completion. *Number for (Enterprise One, All services) 
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Figure 14 Change in pain severity from pathway start to pathway end 
  
   
Percent of patients with moderate or worse ‘average pain’ at 
pathway start who make a clinically significant improvement 
at pathway end 
Patient Carer 
Enterprise One (n=10, 9)* 60.0 55.6 
All services (n=93, 100)* 48.4 58.0 
*Number for (patient, carer) 
Percent of patients with moderate or worse ‘worst pain’ at 
pathway start who make a clinically significant improvement 
at pathway end 
Patient Carer 
Enterprise One (n=12, 10)* 33.3 40.0 
All services (n=121, 110)* 34.7 40.0 
*Number for (patient, carer) 
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Figure 15 Change in PedsQL from pathway start to pathway end 
   
   
    
Percent of patients at risk of impaired health related 
quality of life at pathway start who make a clinically 
significant improvement at pathway end 
Patient Carer 
Enterprise One (n=12, 8)* 58.3 75.0 
All services (n=116, 107)*     71.6     66.4 
*Number for (patient, carer)  
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Table 6  PedsQL — Percent of patients with impaired health related quality of life at pathway start and 
pathway end 
Impaired HRQOL 
Pathway Start Pathway End 
Enterprise One All services Enterprise One All services 
Patient reported 92.3     89.9     69.2     70.2 
Carer reported 80.0     87.1     60.0     65.3 
 
Figure 16 Change in PedsQL Sleep item from pathway start to pathway end, patient reported 
 
Percent of patients with trouble sleeping at 
least ‘sometimes’ at pathway start who 
make a clinically significant improvement at 
pathway end – patient reported 
Enterprise One (n=12) 50.0 
All services (n=105)     32.4 
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Figure 17 Change in PedsQL Sleep item from pathway start to pathway end, carer reported 
 
Percent of patients with trouble sleeping at 
least ‘sometimes’ at pathway start who 
make a clinically significant improvement at 
pathway end – carer reported 
Enterprise One (n=9) 44.4 
All services (n=98) 33.7 
 
 
 
Figure 18 Change in FDI from pathway start to pathway end 
 
Percent of patients with moderate or worse 
functional disability at pathway start who 
make a clinically significant improvement at 
pathway end 
Enterprise One (n=11) 72.7 
All services (n=115) 56.5 
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Figure 19 Change in BAPQ-S5 pain-related worries from pathway start to pathway end 
 
2.1.3 Change from referral to episode end 
Measurement of change from referral to the end of the episode (end of the final pathway) allows 
evaluation of the changes made as a result of the treatment provided.  
Enterprise One received patient referral and episode end questionnaires for 14 episodes. Table 7 shows the 
average change for patients completing the assessment tools at referral and episode end. Responses have 
only been included if the same patient returned questionnaires at both referral and episode end. 
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Table 7  Assessment tools — Change from referral to episode end 
Assessment tool† 
Enterprise One All services 
Score 
at 
referral 
Average 
change 
Valid 
outcome 
number 
Valid 
outcome 
% 
Score 
at 
referral 
Average 
change 
Valid 
outcome 
number 
Valid 
outcome 
% 
Patient 
Pain severity (n=14, 124)*   
     Worst pain 7.6     -2.4           14    100.0 7.6     -2.0          122     98.4 
     Least pain 3.6     -2.0           14    100.0 3.5     -1.3          121     97.6 
     Usual pain 6.1     -2.8           13     92.9 5.7     -2.0          119     96.0 
     Pain now 5.6     -3.0           14    100.0 4.9     -1.8          121     97.6 
PedsQL (n=14, 124)*   
     Sleep 26.8     21.4           14    100.0 31.8     13.9          119     96.0 
     Physical 46.2     16.3           14    100.0 40.8     18.3          121     97.6 
     Emotional 51.4     16.1           14    100.0 47.4     15.6          120     96.8 
     Social 62.9      9.6           14    100.0 63.2      8.2          122     98.4 
     School 50.7      8.2           14    100.0 49.2      9.2          122     98.4 
     Total 51.9     13.0           14    100.0 48.9     13.4          122     98.4 
FDI (n=14, 124)* 25.6    -11.4           14    100.0 26.2     -9.6          122     98.4 
BAPQ-S5 (n=11, 72)* 15.3     -5.4           11    100.0 15.9     -5.2           71     98.6 
Carer 
Pain severity (n= 11, 116)*   
     Worst pain 7.5     -2.5           11    100.0 7.7     -2.3          108     93.1 
     Least pain 4.2     -1.7           11    100.0 3.7     -1.5          110     94.8 
     Usual pain 6.3     -2.5           11    100.0 6.0     -2.3          110     94.8 
     Pain now 5.9     -3.5           11    100.0 5.2     -2.1          111     95.7 
PedsQL (n=11, 116)*   
     Sleep 27.3     27.5           10     90.9 33.2     16.7          108     93.1 
     Physical 44.9     14.0           11    100.0 37.6     19.7          111     95.7 
     Emotional 49.5     17.0           10     90.9 47.6     11.0          109     94.0 
     Social 60.5     13.6           11    100.0 57.2     12.4          110     94.8 
     School 45.0     13.2           11    100.0 46.7     13.4          111     95.7 
     Total 49.3     14.1           11    100.0 45.9     14.5          111     95.7 
BAP-PIQ (n=0, 16)*   
     Depression - -            0 - 14.4     -1.5           16    100.0 
     Anxiety -  -             0 -  9.8     -1.4           16    100.0 
     Catastrophising -  -             0 -  9.4     -1.7           16    100.0 
     Self blame/helplessness -  -             0 -  13.1     -4.2           16    100.0 
     Partner relationship -  -             0 -  11.7     -1.0           14     87.5 
     Leisure functioning -  -             0 -  18.1     -3.0           15     93.8 
     Parental behaviour -  -             0 -  27.4     -4.2           16    100.0 
     Parental strain -  -             0 -  9.3     -1.9           16    100.0 
† See Appendix C for information on item completion. *Number for (Enterprise One, All services) 
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Figure 20 Change in average pain from referral to episode end 
   
Percent of patients with moderate or worse ‘average pain’ at 
referral who make a clinically significant improvement at 
episode end 
Patient Carer 
Enterprise One (n=10, 10)* 60.0 60.0 
All services (n=89, 95)* 52.8 64.2 
*Number for (patient, carer) 
Figure 21 Indicator 1 – Average Pain 
 
* See Appendix E — Interpreting this report 
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Figure 22 Change in worst pain from referral to episode end 
  
Percent of patients with moderate or worse ‘worst pain’ at 
referral who make a clinically significant improvement at 
episode end 
Patient Carer 
Enterprise One (n=13, 11)* 38.5 45.5 
All services (n=116, 101)* 38.8 44.6 
*Number for (patient, carer) 
 
  
 
Patient outcomes in paediatric pain management, 2020 mid-year report 
24 
Figure 23 Change in PedsQL Psychosocial and Physical from referral to episode end 
  
  
Table 8  PedsQL — Percent of patients with impaired health related quality of life at referral and episode 
end 
Impaired HRQOL Referral Episode end 
Enterprise One All services Enterprise One All services 
Patient reported 85.7     89.3     64.3     68.5 
Carer reported 81.8     87.6     54.5     63.2 
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Figure 24 Change in PedsQL Total from referral to episode end 
  
Percent of patients with impaired health related quality of 
life at referral who make a clinically significant 
improvement at episode end 
Patient Carer 
Enterprise One (n=12, 9)* 58.3 77.8 
All services (n=109, 98)* 70.6 67.3 
*Number for (patient, carer) 
Figure 25 Indicator 2 – Paediatric quality of life 
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Figure 26 Change in PedsQL Sleep item from referral to episode end, patient reported 
 
Percent of patients with trouble sleeping at 
least ‘sometimes’ at referral who make a 
clinically significant improvement at episode 
end – patient reported 
Enterprise One (n=12) 50.0 
All services (n=97) 37.1 
 
 
Figure 27 Change in PedsQL Sleep item from referral to episode end, carer reported 
 
Percent of patients with trouble sleeping at 
least ‘sometimes’ at referral who make a 
clinically significant improvement at episode 
end – carer reported 
Enterprise One (n=10) 50.0 
All services (n=92) 37.0 
 
 
  
 
Patient outcomes in paediatric pain management, 2020 mid-year report 
27 
Figure 28 Change in FDI from referral to episode end 
 
Percent of patients with moderate or worse 
functional disability at referral who make a 
clinically significant improvement at episode 
end 
Enterprise One (n=12) 75.0 
All services (n=111) 58.6 
 
 
Figure 29 Indicator 3 – Functional Disability 
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Figure 30 Change in BAPQ-S5 pain-related worries from referral to episode end 
 
2.1.4 Change from referral to post episode  
This section describes change occurring from initial referral to a pain management service to a point three 
to six months after the patients’ episode has ended. This allows evaluation of the changes made as a result 
of the treatment received, and if these changes have been maintained.  
The average change in the outcome measures for patients who completed both a referral and three to six 
month post episode questionnaire (where the post episode questionnaire was returned within the 
reporting period) is shown in Table 9. Enterprise One received referral and post episode questionnaires 
from 5 patients and 5 carers. 
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Table 9  Assessment tools — Change from referral to post episode 
Assessment tool† 
Enterprise One All services 
Score 
at 
referral 
Average 
change 
Valid 
outcome 
number 
Valid 
outcome 
% 
Score 
at 
referral 
Average 
change 
Valid 
outcome 
number 
Valid 
outcome 
% 
Patient 
     Pain severity (n=5, 58)*  
Worst pain 8.0     -2.0            5    100.0 8.0     -2.6           58    100.0 
Least pain 2.0     -0.4            5    100.0 3.8     -1.6           58    100.0 
Usual pain 5.4     -2.0            5    100.0 6.0     -2.5           57     98.3 
Pain now 4.2     -0.8            5    100.0 5.3     -2.4           57     98.3 
     PedsQL (n=5, 58)  
Sleep 43.8     25.0            4     80.0 30.8     25.0           56     96.6 
Physical 50.8     15.6            4     80.0 37.2     25.8           56     96.6 
Emotional 56.3     17.5            4     80.0 49.6     20.0           56     96.6 
Social 75.0     -7.5            4     80.0 68.1      6.4           55     94.8 
School 52.5     13.8            4     80.0 48.7     15.7           56     96.6 
Total 57.6     10.6            4     80.0 49.1     18.3           56     96.6 
     FDI (n=5, 57) 22.4     -9.6            5    100.0 26.5    -12.3           57    100.0 
     BAPQ-S5 (n=3, 35) 12.3     -6.7            3    100.0 16.8     -7.4           35    100.0 
Carer 
     Pain severity (n= 5, 58)  
Worst pain 8.0     -2.0            4     80.0 8.1     -3.3           54     93.1 
Least pain 2.8     -1.3            4     80.0 4.6     -2.3           54     93.1 
Usual pain 5.3     -2.3            4     80.0 6.5     -3.3           55     94.8 
Pain now 5.3     -1.8            4     80.0 6.1     -3.2           56     96.6 
     PedsQL (n=5, 58)  
Sleep 50.0      0.0            5    100.0 35.5     18.0           57     98.3 
Physical 49.4     10.6            5    100.0 30.8     27.4           58    100.0 
Emotional 54.5      3.8            5    100.0 48.5     14.5           58    100.0 
Social 59.0     12.0            5    100.0 60.4     14.1           58    100.0 
School 56.0     14.0            5    100.0 43.7     21.4           57     98.3 
Total 54.1     10.1            5    100.0 44.0     20.3           58    100.0 
     BAP-PIQ (n=1, 12)  
Depression 19.1     -8.1            1    100.0 14.1     -2.2           12    100.0 
Anxiety 8.4     -3.4            1    100.0 9.6     -2.9           12    100.0 
Catastrophising 7.0     -5.0            1    100.0 8.3     -1.0           12    100.0 
Self-blame/helplessness 6.0     -3.0            1    100.0 8.8     -0.9           12    100.0 
Partner relationship - -             0      0.0 10.6     -2.4            8     66.7 
Leisure functioning 15.0     -4.0            1    100.0 18.0     -2.8           12    100.0 
Parental behaviour 19.0     -3.0            1    100.0 29.0     -8.8           11     91.7 
Parental strain 10.0     -2.0            1    100.0 7.7      0.0           11     91.7 
† See Appendix C for information on item completion. *Number for (Enterprise One, All services) 
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Figure 31 Change in pain severity from referral to post episode 
   
   
Percent of patients with moderate or worse ‘average pain’ at 
referral who make a clinically significant improvement post 
episode 
Patient Carer 
Enterprise One (n=4, 2)* 25.0 50.0 
All services (n=47, 48)* 53.2 64.6 
*Number for (patient, carer) 
Percent of patients with moderate or worse ‘worst pain’ at 
referral who make a clinically significant improvement post 
episode 
Patient Carer 
Enterprise One (n=5, 4)* 40.0 25.0 
All services (n=57, 52)* 38.6 46.2 
*Number for (patient, carer) 
 
  
 
Patient outcomes in paediatric pain management, 2020 mid-year report 
31 
Figure 32 Change in PedsQL from referral to post episode 
   
   
    
Percentage of patients with impaired health related quality 
of life at referral who make a clinically significant 
improvement post episode 
Patient Carer 
Enterprise One (n=3, 4)* 66.7 75.0 
All services (n=48, 52)* 66.7 73.1 
*Number for (patient, carer) 
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Table 10 PedsQL — Percent of patients with impaired health related quality of life at referral and post-
episode 
Impaired HRQOL Referral Post-episode 
Enterprise One All services Enterprise One All services 
Patient reported 75.0     85.7     60.0     53.4 
Carer reported 80.0     89.7     60.0     48.3 
 
Figure 33 Change in PedsQL Sleep item from referral to post episode, patient reported 
 
Percent of patients with trouble sleeping at 
least ‘sometimes’ at referral who make a 
clinically significant improvement at post 
episode – patient reported 
Enterprise One (n=3) 66.7 
All services (n=43) 46.5 
 
 
 
Figure 34 Change in BAPQ-S5 pain-related worries from referral to post episode 
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Figure 35 Change in PedsQL Sleep item from referral to post episode, carer reported 
 
Percent of patients with trouble sleeping at 
least ‘sometimes’ at referral who make a 
clinically significant improvement at post 
episode – carer reported 
Enterprise One (n=4) 50.0 
All services (n=42) 40.5 
 
 
Figure 36 Change in FDI from referral to post episode 
 
Percent of patients with moderate or worse 
functional disability at referral who make a 
clinically significant improvement at post 
episode 
Enterprise One (n=5) 40.0 
All services (n=48) 58.3 
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2.2 Outcome measure 2 — Medication use 
Pain management services collect information about patient’s medication (as reported by their carer) and 
the frequency of their use. The Figures below show medication use for Enterprise One patients compared 
to patients for All services for questionnaires returned during the reporting period. The reporting period for 
this data is all patients from referral to the most recent questionnaire.  
Figure 37 Medication use — Paracetamol only medicines 
 
Figure 38 Medication use — Anti-inflammatory medicines (non-prescription) 
 
Figure 39 Medication use — Anti-inflammatory medicines (prescription) 
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Figure 40 Medication use — Complementary or alternative medicines 
 
Figure 41 Medication use — Opioid medicines containing codeine  
 
Figure 42 Medication use — Opioid medicines other than codeine  
 
Figure 43 Medication use — Medication for nerve pain 
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2.3 Outcome measure 3 — Pain frequency  
Table 11 and Table 12 show the change in the % of patients at each level of pain frequency between 
referral and episode end, and referral and post episode respectively.  Data in this section are collected from 
all carers who returned a questionnaire at the end of the episode, or 3-6 months post episode in the 
reporting period. 
Table 11 Pain frequency — referral to episode end 
Pain frequency 
(carer reported) 
Enterprise One All services 
Referral Episode end Referral Episode end  
n=11 n=113 
Always present (same intensity) 18.2   9.1 8.0   1.8 
Always present (varying intensity) 63.6  36.4 56.6  39.8 
Often present 0.0  18.2 24.8  13.3 
Occasionally present 0.0   9.1 8.0  18.6 
Rarely present 18.2   0.0 2.7  14.2 
No longer present 0.0  27.3 0.0  12.4 
 
 
Table 12 Pain frequency — referral to post episode 
Pain frequency 
(carer reported) 
Enterprise One All services 
Referral Post-episode Referral Post-episode  
n=5 n=56 
Always present (same intensity) 20.0   0.0 19.6   8.9 
Always present (varying intensity) 20.0  40.0 64.3  30.4 
Often present 40.0  20.0 10.7  14.3 
Occasionally present 20.0  20.0 3.6  16.1 
Rarely present 0.0   0.0 1.8   7.1 
No longer present 0.0  20.0 0.0  23.2 
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2.4 Outcome measure 4 — School/work impact 
Table 13 to Table 15 show the impact of pain on the child’s school attendance and ability to work.  
Table 16 and Table 17 show the impact on the carer’s ability to work.  
Table 13 Median number of school days missed in previous two weeks 
School days missed 
(carer reported) 
Enterprise One All services 
Referral Episode 
end 
Post-
episode 
Referral Episode 
end 
Post-
episode 
n=48 n=15 n=6 n=355 n=163 n=61 
Young child -      1.0 -  1.0      1.0      1.0 
Child 2.0      1.0      0.5 2.0      0.0      0.0 
Adolescent 6.0      1.0      1.0 3.0      1.0      0.0 
 
Table 14 Patient employment status (%) — referral to episode end 
Employment status  
Enterprise One All services 
Referral Episode end Referral Episode end 
n=10 n=68 
Working full-time 0.0   0.0 2.9   0.0 
Working part-time/casually 10.0  30.0 19.1  32.4 
Unable to work due to pain  0.0   0.0 13.2  10.3 
Unable to work due to a condition 
other than pain 
0.0   0.0 0.0   2.9 
Not working by choice 0.0  10.0 7.4  16.2 
Seeking employment 10.0   0.0 5.9   8.8 
Too young to work 80.0  60.0 54.4  29.4 
Total 100.0 100.0 100.0 100.0 
 
Table 15 Patient work productivity and impairment (%) — referral to episode end 
Work productivity and impairment  
Enterprise One All services 
Referral Episode end Referral Episode end 
Work time missed due to pain  
(n=1, 10) 
0.0   9.1 10.0   9.7 
Pain affected work productivity  
(n=1, 7) 
70.0  30.0 51.4  40.0 
Overall work impairment (n=1, 7) 70.0  36.4 51.4  45.9 
NOTE: (n = Number for your service, Number for all services) 
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Table 16 Carer employment status (%) — referral to episode end 
Employment status  
Enterprise One All services 
Referral Episode end Referral Episode end 
n=9 n=106 
Working full-time 22.2  22.2 34.9  38.7 
Working part-time 44.4  44.4 31.1  33.0 
Unable to work due to child’s pain  22.2  11.1 14.2  10.4 
Not working by choice 11.1  11.1 17.9  15.1 
Seeking employment 0.0  11.1 1.9   2.8 
Total 100.0 100.0 100.0 100.0 
 
Table 17 Carer work productivity and impairment (%) — referral to episode end 
Work impairment and productivity  
Enterprise One All services 
Referral Episode end Referral Episode end 
Work time missed due to child’s 
pain (n=5, 49) 
21.5   0.0 23.1  13.2 
Child’s pain affected work 
productivity (n=3, 38) 
13.3  23.3 45.8  30.5 
Overall work impairment (n=3, 34) 15.6  23.3 54.2  38.4 
NOTE: (n = Number for your service, Number for all services) 
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2.5 Outcome measure 5 — Health service use  
Information about health service use is collected from carers as an outcome measure. At first glance, a 
reduction in health service use may appear to be a positive outcome, however, increased health service use 
may in fact reflect more appropriate use of services, for example a patient seeking regular sessions with 
allied health providers to assist in managing their pain. Caution should therefore be used in interpreting the 
information in Table 18.  
Table 18 shows the median and mean number of times Enterprise One patients used each service in the 
last 3 months compared to All services for patients who returned a referral, episode end, and/or post 
episode questionnaire in the reporting period.  
Table 18 Health service use (median and mean number of times used in the last 3 months due to pain) 
Health service use – median / 
mean 
(carer reported) 
Enterprise One All services 
Referral Episode 
end 
Post-
episode 
Referral Episode 
end 
Post-
episode 
General practitioner 3.0 / 3.2 0.0 / 0.4 1.0 / 1.3 2.0 / 3.5 0.0 / 1.2 0.0 / 1.1 
Medical specialist 2.0 / 3.3 1.0 / 1.3 0.0 / 1.1 2.0 / 2.8 1.0 / 1.3 0.0 / 0.8 
Other health professionals  3.0 / 5.0 1.5 / 2.9 2.0 / 1.9 2.0 / 4.3 2.0 / 3.4 1.0 / 2.8 
Other therapist 0.0 / 1.3 0.0 / 1.2 0.0 / 0.7 0.0 / 1.1 0.0 / 0.8 0.0 / 0.4 
Hospital emergency department 0.0 / 0.8 0.0 / 0.1 0.0 / 0.6 0.0 / 0.9 0.0 / 0.3 0.0 / 0.2 
Admitted to hospital 0.0 / 0.2 0.0 / 0.0 0.0 / 0.3 0.0 / 0.4 0.0 / 0.1 0.0 / 0.1 
Diagnostic tests 2.0 / 2.3 0.0 / 0.4 0.0 / 1.7 2.0 / 2.0 0.0 / 0.9 0.0 / 0.5 
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2.6 Outcome measure 6 — Time from referral to first contact 
Table 19 shows the distribution of waiting time from referral to episode start, and the average and median 
time from referral to episode start for Enterprise One compared to All services for episodes that start 
within the reporting period. Time from referral to episode start is calculated as the date the referral is 
received to the episode start date (defined as the first clinical contact).  
Table 19 Time from referral to first contact 
Time from referral to episode 
start 
Enterprise One All services 
Number % Number % 
<1 month 15     30.0 121     28.5 
1-<3 months 15     30.0 165     38.9 
3-<6 months 13     26.0 91     21.5 
6-12 months 7     14.0 41      9.7 
>12 months 0      0.0 6      1.4 
Average (days) 85.4 - 81.9 - 
Median (days) 55.5 - 56.0 - 
Within 8 weeks 25     50.0 216     50.9 
 
Figure 44 Benchmark 1 - Time from referral to episode start 
 
Note: If there is no red dot on your graph this indicates that your service reported less than 10 outcomes 
for this indicator 
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Section 3 — Descriptive analysis 
There are four levels of ePPOC data items – patient, episode, pathway and service events. The broad detail 
is found at the patient level, where the data items describe patient demographics.  
The items at the episode level describe the way that pain management episodes start and end and include 
information about the patient’s pain and comorbidities at the start of the episode. The items at the pathway 
level categorise the type of intervention(s) the patient received, while the service event data items detail 
these interventions and allow evaluation of the intensity of treatment provided.  
This section provides an overview of the data submitted by Enterprise One at each level for the current 
reporting period. Summaries of the data for All services are included for comparative purposes. See Appendix 
C for information on item completion. 
3.1 Summary of activity occurring during this reporting period 
Table 20 describes the service event activity reported by Enterprise One during the current reporting 
period.  
Table 20 Service event activity this reporting period 
Service intensity (total hours) 
Enterprise One 
Total Telehealth 
Individual appointment with medical practitioner 6.2      4.5 
Individual appointment with physiotherapist 35.3      0.5 
Individual appointment with psychologist 80.0     16.0 
Individual appointment with occupational therapist 43.5      4.5 
Individual appointment with nurse 1.8      1.5 
Individual appointment with one or more clinicians 97.9     23.2 
Individual appointment – other 37.0     10.0 
Multidisciplinary team assessment 98.9     10.1 
Multidisciplinary panel discussion 23.4      0.0 
Telephone/ email consultation with patient/carer 24.8      5.6 
Telephone/email consultation with another clinician 9.3      0.0 
Pain management program – group 0.0      0.0 
Pain management program – individual 168.0      0.0 
Procedural intervention – implant (drug delivery) 0.0      0.0 
Procedural intervention – implant (neurostimulation) 0.0      0.0 
Procedural intervention – non-implant 0.0      0.0 
Procedural intervention – cancer block 0.0      0.0 
Procedural intervention – other 0.0      0.0 
Education/orientation program 0.0      0.0 
Other 1.4      0.0 
Total 627.6     75.8 
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Figure 45 Highest duration service events by type this reporting period (as a percent of your service’s 
total hours) 
  
 
Patient outcomes in paediatric pain management, 2020 mid-year report 
43 
3.2 Profile of pain management patients 
The information collected about each patient includes gender, indigenous status, country of birth, and 
whether a patient requires help with communication.  
Table 21 to Table 23 describe patients at Enterprise One compared to those at All services for patients 
active in the reporting period.  
Table 21 Gender  
Gender 
Enterprise One All services 
Number % Number % 
Male 27     27.0 258     30.9 
Female 73     73.0 575     68.9 
Not stated/described 0      0.0 1      0.1 
Total 100    100.0 834    100.0 
 
Table 22 Indigenous status  
Indigenous status 
Enterprise One All services 
Number % Number % 
Aboriginal but not Torres Strait Islander origin 1      1.1 29      3.9 
Torres Strait Islander but not Aboriginal origin 0      0.0 2      0.3 
Both Aboriginal & Torres Strait Islander origin 0      0.0 1      0.1 
Neither Aboriginal nor Torres Strait Islander 
origin 
91     98.9 703     95.6 
Total 92    100.0 735    100.0 
 
Table 23 Country of birth  
Country of birth 
Enterprise One All services 
Number % Number % 
Australia 84     92.3 668     91.6 
New Zealand 1      1.1 7      1.0 
Other 6      6.6 54      7.4 
Total 91    100.0 729    100.0  
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Figure 46 Socioeconomic disadvantage quintile (based on patient area of residence) at referral 
 
* See Appendix E — Interpreting this report  
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3.3 Profile of pain management episodes 
An episode of care is a continuous period of care for a patient in one pain management service.  
An episode begins with the first clinical contact with the patient and ends when active treatment is 
completed.  
Episodes at Enterprise One are described in comparison to those at All services in the following tables for 
active episodes in the reporting period. 
Table 24 Age at referral for male and female 
Age at referral 
Enterprise One All services 
Male Female Male Female 
Average age (years) 11.4     13.1 11.8     13.0 
Median age (years) 11.0     13.0 12.0     14.0 
 
Table 25 Age group at referral for male and female — distribution 
Age group 
at referral 
Enterprise One All services 
Male Female Male Female 
Number % Number % Number % Number % 
< 8 2      7.1            2      2.7 24      9.2           25      4.3 
8-12 15     53.6           24     32.4 121     46.2          174     29.6 
13+ 11     39.3           48     64.9 117     44.7          388     66.1 
Total 28    100.0           74    100.0 262    100.0          587    100.0 
 
Table 26 Body Mass Index (BMI) at referral 
BMI1 
Enterprise One All services 
Number % Number % 
Underweight (less than 5th percentile) 5      6.9 38      7.0 
Healthy weight (5th to 85th percentile) 36     50.0 298     55.1 
Overweight (85th to 95th percentile) 18     25.0 109     20.1 
Obese (95th percentile and above) 13     18.1 96     17.7 
Total 72    100.0 541    100.0 
* See Appendix E — Interpreting this report  
 
  
                                                             
1 CDC Growth Chart, 2000, Centers for Disease Control and Prevention. https://www.cdc.gov/growthcharts/ 
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Table 27 School level at referral 
Level of school 
Enterprise One All services 
Number % Number % 
Preschool 0      0.0 3      0.7 
Primary school 14     25.5 127     30.8 
Secondary school 40     72.7 276     67.0 
Other 1      1.8 6      1.5 
Total 55    100.0 412    100.0  
 
Table 28 Main pain area at referral 
Main pain area (patient reported)* 
Enterprise One All services 
Number % Number % 
Head 7     17.1 52     13.5 
Neck 0      0.0 9      2.3 
Chest 0      0.0 15      3.9 
Back 8     19.5 76     19.8 
Leg 4      9.8 41     10.7 
Arm/shoulder 3      7.3 19      4.9 
Abdomen 8     19.5 50     13.0 
Hands 2      4.9 14      3.6 
Feet 4      9.8 36      9.4 
Pelvic/genital 0      0.0 7      1.8 
Knee 2      4.9 39     10.2 
Hip 3      7.3 26      6.8 
Total 41    100.0 384    100.0  
* See Appendix B — Assessment tools for description of pain areas 
Table 29 Number of pain areas at referral 
Number of pain areas (patient reported) 
Enterprise One All services 
Number % Number % 
1 15     29.4 99     24.1 
2-3 20     39.2 143     34.8 
4-6 11     21.6 112     27.3 
7-9 5      9.8 47     11.4 
10+ 0      0.0 10      2.4  
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Table 30 Referral source 
Referral source 
Enterprise One All services 
Number % Number % 
General practitioner / Nurse practitioner (not an 
admitted patient) 
24     23.5 186     21.9 
Specialist practitioner (not an admitted patient) 61     59.8 542     63.8 
Other pain management service 0      0.0 5      0.6 
Public hospital (incl. emergency or outpatient 
department) 
16     15.7 110     12.9 
Private hospital (incl. emergency or outpatient 
department) 
0      0.0 2      0.2 
Rehabilitation provider / private insurer 0      0.0 0      0.0 
Other 1      1.0 5      0.6 
Total 102    100.0 850    100.0  
 
Table 31 Cause of pain (precipitating event) 
Cause of pain 
(carer reported) 
Enterprise One All services 
Number % Number % 
Injury 15     18.1 130     18.6 
After surgery 5      6.0 41      5.9 
Illness 16     19.3 121     17.3 
No known cause 28     33.7 268     38.3 
Other 19     22.9 139     19.9 
Total 83    100.0 699    100.0  
 
Table 32 Pain duration 
Pain duration 
(carer reported) 
Enterprise One All services 
Number % Number % 
Less than 3 months 7      8.3 61      8.7 
3 to 12 months 21     25.0 185     26.3 
More than 12 months 56     66.7 457     65.0 
Total 84    100.0 703    100.0 
 
Table 33 Compensation/legal status 
Is there a legal / compensation case relating to 
the child’s pain problem? 
(carer reported) 
Enterprise One All services 
Number % Number % 
Yes 1      1.2 23      3.3 
No 83     98.8 678     96.7 
Total 84    100.0 701    100.0  
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Table 34 First attendance at specialist pain service 
Is this the first time your child has attended a 
specialist pain service? (carer reported) 
Enterprise One All services 
Number % Number % 
Yes 11     12.9 121     17.2 
No 74     87.1 582     82.8 
Total 85    100.0 703    100.0  
 
Table 35 Comorbidities and disabilities at referral 
Comorbidities 
Enterprise One All services 
Number %* Number %* 
Comorbidities     
Chronic disease 27     26.5 200     23.5 
Mental health condition 25     24.5 222     26.1 
Cancer 1      1.0 19      2.2 
Disabilities     
Sight impairment 6      5.9 53      6.2 
Hearing impairment 0      0.0 23      2.7 
Intellectual disability 3      2.9 36      4.2 
Physical disability 8      7.8 89     10.5  
* Note that the %s in this table will not sum to 100% as patients may have any number of comorbidities 
and/or disabilities. 
Table 36 Episode start mode 
Episode start mode 
Enterprise One All services 
Number % Number % 
Multidisciplinary assessment and/or treatment 65     78.3 516     72.1 
Single clinician assessment and/or treatment  18     21.7 195     27.2 
Education / orientation program  0      0.0 5      0.7 
Total 83    100.0 716    100.0 
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Table 37 Episode end mode 
Episode end mode 
Enterprise One All services 
Number % Number % 
Treatment complete – self management / 
referral to primary care 
20     40.0 193     47.1 
Referral to another pain service 1      2.0 7      1.7 
Patient discontinued by choice 7     14.0 34      8.3 
Died  0      0.0 0      0.0 
Active treatment complete (ongoing review) 10     20.0 65     15.9 
Referral did not proceed to episode start  9     18.0 80     19.5 
Lost to contact / not to follow up  3      6.0 31      7.6 
Other 0      0.0 0      0.0 
Total 50    100.0 410    100.0 
 
Table 38 Length of episode (lapsed days) — summary 
Length of episode Enterprise One All services 
Average length of episode  286.1 260.6 
Median length of episode 184.0 190.0 
 
Table 39 Length of episode (lapsed days) — distribution 
Length of episode 
Enterprise One All services 
Number % Number % 
<1 month 3      6.0 31      7.3 
1-2 months 4      8.0 38      8.9 
3-6 months 16     32.0 136     31.9 
7-9 months 9     18.0 74     17.4 
10-12 months 8     16.0 62     14.6 
>12 months 10     20.0 85     20.0 
Total 50    100.0 426    100.0  
 
  
 
Patient outcomes in paediatric pain management, 2020 mid-year report 
50 
Table 40 Number of pathways per episode (for completed episodes) 
Pathways per episode 
Enterprise One All services 
Number % Number % 
1 35    100.0 309     97.8 
2 0      0.0 7      2.2 
3 0      0.0 0      0.0 
4 0      0.0 0      0.0 
5 0      0.0 0      0.0 
6 0      0.0 0      0.0 
7 0      0.0 0      0.0 
8 or more 0      0.0 0      0.0 
Total 35    100.0 316    100.0  
 
Table 41 Service intensity — time per episode (for completed episodes) 
Service intensity (total hours) 
Enterprise One All services 
Number % Number % 
<5 hours 17     35.4 131     32.3 
5-9 hours 9     18.8 100     24.6 
10-19 hours 14     29.2 91     22.4 
20-49 hours 6     12.5 59     14.5 
50+ hours 2      4.2 25      6.2 
Total 48    100.0 406    100.0 
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3.4 Profile of pain management pathways 
The pain management pathway type describes the broad type of intervention. There are four pain 
management pathway types:  
 group pain management program(s)  
 individual appointment(s)  
 concurrent (both group and individual appointments)  
 one-off intervention.  
Each episode would generally include one or more pathways, and the pathways can occur in any sequence.  
Information on active pathways within an episode is presented in Table 42 to Table 45.  
Table 42 Number of pathways by pathway type 
Pathway type 
Enterprise One All services 
Number % Number % 
Group                         2      2.7 34      5.3 
Individual                   71     97.3 593     92.2 
Concurrent                   0      0.0 9      1.4 
One-off                      0      0.0 7      1.1 
All pathways 73    100.0 643    100.0  
 
Table 43 Average pathway length (lapsed days) by pathway type 
Pathway type Enterprise One All services 
Group                         29.0 83.0 
Individual                   200.5 212.7 
Concurrent                   - 240.8 
One-off                      - 32.5  
 
Table 44 Pathway delivery mode 
Pathway delivery mode 
Enterprise One All services 
Number % Number % 
Care plan only 0      0.0 3      0.5 
Remotely supported care 1      1.4 15      2.4 
In clinic care 70     98.6 600     97.1 
Total 71    100.0 618    100.0  
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Table 45 Service intensity — time per pathway (for completed pathways) 
Service intensity 
(total hours) 
Enterprise One All services 
Number % Number % 
<5 hours 12     35.3 123     37.7 
5-9 hours 9     26.5 94     28.8 
10-19 hours 8     23.5 59     18.1 
20-49 hours 3      8.8 37     11.3 
50+ hours 2      5.9 13      4.0 
Total 34    100.0 326    100.0  
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Appendix A — Data scoping 
The scope for the information in the ePPOC reports can be split into two types. The first looks at patient-
level change over a pathway or episode. The second uses the activity during the reporting period. 
Change in patient outcomes over a pathway or episode 
Outcomes for episodes or pathways are only included where a patient completes both a start and end 
questionnaire, and the end questionnaire is completed within the reporting period. The start questionnaire 
does not necessarily need to be completed in the same reporting period. Section 2.1 (Patient outcomes– 
Standard assessment tools) uses this method. 
Activity during the reporting period 
All other information is based on activity in the reporting period. The completion of a questionnaire or the 
occurrence of a service event determines whether a patient, episode or pathway is ‘active’. Sections 2.2, 
2.3 and 2.4 report on completed questionnaires in the reporting period. This means that the data in each 
column is not necessarily for the same patients. 
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Appendix B — Assessment tools 
The assessment tools used in this report are:  
 Modified Brief Pain Inventory (BPI) (Pain severity) 
 Faces Pain Scale – Revised (Pain severity) 
 Paediatric Quality of Life Inventory (PedsQL)  
 Functional Disability Inventory (FDI)  
 Bath Adolescent Pain Questionnaire – Pain-related worry section (BAPQ-S5) 
 Bath Adolescent Pain – Parent Impact Questionnaire (BAP-PIQ) 
 Work Productivity and Impairment (WPAI) 
 CARRA Body Chart.  
The tool used to capture pain severity is dependent on the patient’s age.  Patients aged 8 and above use 
the Modified Brief Pain Inventory, whereas patients aged 5-7 use the Faces Pain Scale. Each of these 
assessment tools are briefly described below.  
Modified Brief Pain Inventory (BPI)2 
Modified versions of the questions in the standard BPI are used in PaedePPOC to assess pain in patients 
aged 8 and over, and a parent proxy rating of their child’s pain for all ages.  
Faces Pain Scale – Revised3 
Children choose one of six faces showing increasing levels of pain, from ‘no pain’ to ‘very much pain’ and 
corresponding numerically to 0, 2, 4, 6, 8, 10. 
For both tools, questions are rated on a scale of 0 (‘No pain’) to 10 (‘Pain as bad as you can imagine’),  
with patients asked their average, worst and least pain over the last week, and their pain right now. 
Severity bands for these items are: 
 0-4 = mild pain 
 5-6 = moderate pain 
 7-10 = severe pain 
Pain severity is calculated as an average of the four pain items mentioned above.  
The IMMPACT group’s recommendations for assessing clinical significance for 0-10 numeric pain scales are 
that a change of:  
≥ 10% represents minimally important change  
≥ 30% represents moderate clinically important change (ePPOC uses this category to identify clinically 
significant improvement for average and worst pain) 
≥ 50% represents substantial clinically important change 4.  
  
                                                             
2 Modified Brief Pain Inventory, © 1991. Reproduced with acknowledgement of the Pain Research Group, University of 
Texas, MD Anderson Cancer Centre, USA. www.mdanderson.org 
3 Faces Pain Scale – Revised, © 2001, International Association for the Study of Pain. www.iasp-pain.org/RPSR 
4 Eccleston, C et al 2005, ‘The Bath Adolescent Pain Questionnaire (BAPQ-S5): Development and preliminary 
psychometric evaluation of an instrument to assess the impact of chronic pain on adolescents’, Pain, vol. 118 num. 1-
2, pp 263-270. (Source: Bath Centre for Pain Research www.bath.ac.uk/pain) 
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Paediatric Quality of Life Inventory (PedsQL)56 
PaedePPOC uses the PedsQL Generic Core Scales to measure health-related quality of life. Parents and all 
patients complete the age-appropriate version. Items are rated on a five point scale where 0=’Never’  
[a problem] and 4=’Almost always’ [a problem]. For 5-7 year olds the scale is clinician administered and 
rated on a three point scale where 0=’Never’ [a problem], 2=’Sometimes [a problem] and 4=’Almost always’ 
[a problem].  
Results are reported as four scale scores (physical, emotional, social and school functioning) and two 
summary scores (psychosocial and physical health), with higher scores indicating better health-related 
quality of life. If more than 50% of the items in a scale are missing, the scale scores should not be computed 
and are not reported. Detailed scoring instructions can be found at: www.pedsql.org/score.html  
Minimal clinically meaningful difference on the PedsQL is measured as a:  
 4.4 change in the child self-report total score  
 4.5 change in adult proxy-report total score.   
This definition is used to represent a clinically significant increase in this report. 
For the PedsQL ‘Sleep’ item, clinically significant improvement is reported for patients with trouble sleeping 
at least sometimes (sleep item score = 2). The improvement is classed as clinically significant if the score for 
sleep is reduced by at least 50%. 
“At risk status” for impaired HRQOL is reflected in a:  
 Total score below 69.7 for child self-report  
 Total score below 65.4 for adult proxy-report.   
For the sake of brevity, throughout this report “At risk status for impaired HRQOL” is simply referred to as 
“impaired HRQOL”. 
Functional Disability Inventory (FDI)7 
The FDI is a 15 item assessment tool which asks patients whether they have had any physical trouble or 
difficulty doing specified activities. Items are rated on a five point scale where 0=’No trouble’ and 
4=’Impossible’.  
Severity bands for the FDI are:  
 0-12 = No/minimal disability  
 13-29 = Moderate disability  
 >29 = Severe disability  
Clinically significant change is indicated where there is a change of 5 or more points coupled with a change 
to a different severity category. 
Bath Adolescent Pain Questionnaire – Pain-related worry section (BAPQ-S5) 
Section 5 of the BAPQ-S5 asks patients about specific worries or concerns they have about their pain.  
There are seven items rated on a five point scale of ‘Never’ to ‘Always’.  
                                                             
5 Varni, JW 1998, Paediatric Quality of Life Inventory (PedsQL™). 
6 Varni, JW, et al. 2005, ‘The PedsQL as a Pediatric Patient-Reported Outcome: Reliability and Validity of the PedsQL 
Measurement Model in 25,000 Children’, Expert Review of Pharmacoeconomics Outcomes Research, vol. 5 num. 6, pp 
705-718. 
7 Walker LS and Greene JW 1991, ‘The Functional Disability Inventory (FDI): Measuring a neglected dimension of child 
health status’, Journal of Paediatric Psychology, vol. 16 num 1, pp 39-58. 
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Bath Adolescent Pain – Parent Impact Questionnaire (BAP-PIQ)8 
The impact of the child’s pain on the parent is measured over eight subscales:  depression, anxiety,  
child-related catastrophising, self-blame and helplessness, partner relationship, leisure functioning, 
parental behaviour and parental strain. All items are rated on a 5 point scale, ranging from 0 (never)  
to 4 (always).  
 
Work Productivity and Impairment (WPAI)9 
The work status of all patients is collected using the International Consortium for Health Outcomes 
Measurement (ICHOM) categories. For patients that are employed, the WPAI items allow calculation of the 
following outcomes: 
 % of time missed from work due to pain (absenteeism) 
 % work impairment while working due to pain (lost productivity) 
 % overall work impairment due to pain (taking into account absenteeism and lost productivity). 
CARRA Body Chart10 
Patients identify the site/s they feel pain using body maps. For reporting, pain sites are categorised into 
pain areas as follows: 
 Pain sites 
Head head and face 
Neck neck 
Chest chest 
Back upper back, mid back and low back  
Leg left and right thighs, left and right calves, left and right ankles 
Arm/shoulder 
left and right shoulders, left and right upper arms, left and right elbows, 
left and right forearms, left and right wrists 
Abdomen abdomen 
Hands left and right hands 
Feet left and right feet 
Pelvic/genital pelvic/groin 
Knee left and right knees 
Hip left and right hips 
 
  
                                                             
8 Jordan A et al 2008, ‘The Bath Adolescent Pain – Parental Impact Questionnaire (BAP-PIQ): development and 
preliminary psychometric evaluation of an instrument to assess the impact of parenting an adolescent with chronic 
pain’, Pain, vol. 137 num. 3, pp 478-487. (Source: Bath Centre for Pain Research www.bath.ac.uk/pain) 
9 Reilly MC, Zbrozek AS, Dukes E 1993, ‘The validity and reproducibility of a work productivity and activity impairment 
measure’, PharmacoEconomics, vol. 4, num. 5, pp 353-365. 
10 Von Bayer CL, et al. 2011, ‘Pain charts (body maps or manikins) in assessment of location of paediatric pain’, Pain 
Management, vol. 1 num. 1, pp 61-68. (Source: Childhood Arthritis and Rheumatology Research Alliance, 
www.carragroup.org) 
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Appendix C — Item completion 
Many items collected in epiCentre are mandatory. This section contains item completion information on 
those variables that are not mandatory.  
Table 46 Item completion (percent complete) — patient level 
Data item Enterprise One All services 
Indigenous status 92.0 88.1 
Country of birth 91.0 87.4  
 
Table 47 Item completion (percent complete) — episode level 
Data item Enterprise One All services 
Main pain site 75.9 87.4 
Cause of pain 92.7 94.5 
Pain duration 92.7 94.8 
Health service use  
General practitioner 97.4 96.0 
Specialist 97.4 96.4 
Allied Health 94.8 95.7 
Other therapist 96.1 95.3 
ED 98.7 94.9 
Hospital admission 96.1 94.6 
Diagnostic tests 97.4 95.5  
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Table 48 Item completion — assessment tools 
Outcome measure 
Validity - 
Number of 
completed 
items 
required 
Enterprise One All services 
Average 
number of 
completed 
items 
% of validly 
completed 
questionnaires 
Average number 
of completed 
items 
% of validly 
completed 
questionnaires 
Pain severity  
Worst pain 1/1 -     97.5 -     99.0 
Least pain 1/1 -     97.5 -     98.3 
Average pain 1/1 -     96.2 -     98.2 
Pain now 1/1 -     97.5 -     98.3 
BAPQ-S5  
Pain Specific Anxiety 6/7 6.6     94.2 6.9     98.1 
FDI 12/15 14.5     96.2 14.7     98.5 
PedsQL  
Physical 4/8 7.8     97.5 7.8     98.3 
Emotional 3/5 4.7     94.9 4.8     96.9 
Social 3/5 4.8     96.2 4.9     97.6 
School 3/5 4.8     97.5 4.9     97.5 
Total 12/23 22.6     97.5 22.7     98.5  
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Table 49 Questionnaires returned 
Questionnaires returned 
Enterprise One All services 
Number of 
questionnaires 
created† 
Percent of 
questionnaires 
returned* 
Number of 
questionnaires 
created† 
Percent of 
questionnaires 
returned* 
Patient  
Referral 67 79.1 517 78.3 
Pathway start 9 44.4 78 56.4 
Group program start 
(concurrent pathways) 
0 -  2 100.0 
Pathway review 5 20.0 51 43.1 
Group program end 
(concurrent pathways) 
0 - 0 - 
Pathway end 29 41.4 290 49.0 
Post-episode 25 24.0 235 24.7 
Ad hoc 3 66.7 53 69.8 
Carer  
Referral 67 79.1 521 77.9 
Pathway start 9 33.3 77 50.6 
Group program start 
(concurrent pathways) 
0 - 2 50.0 
Pathway review 5 0.0 50 46.0 
Group program end 
(concurrent pathways) 
0 - 0 - 
Pathway end 29 37.9 294 45.6 
Post-episode 25 24.0 239 26.4 
Ad hoc 3 66.7 53 62.3 
† The number of questionnaires created in epiCentre. 
* The number of questionnaires returned in the reporting period as a % of the number sent. 
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Appendix D — Relationship between levels of ePPOC data 
Five different levels of information are collected in epiCentre. These are:  
1. Patient (e.g. date of birth, country of birth). Carer information is associated with patient records.  
2. Episode – relating to the period of care at the pain service (e.g. referral date, comorbidities).  
A patient may have one or more episodes of care at one pain service or at different pain services.  
3. Pathway – the type(s) of intervention provided to the patient. These can be group pain programs, 
individual appointments, one off interventions, or a combination of group pain and individual 
appointments occurring concurrently. A patient may follow one or more pathways during an 
episode of care at a pain service.  
4. Service event – the services provided to the patient during an episode of care.  
5. Questionnaire – the patient and carer reported outcome measures e.g. FDI, PedsQL.  
 
Below is an example of how these levels of information are structured:  
 
  
Patient and carer reported outcomes are collected at:  
 Referral – to record a baseline measure  
 Pathway starts and ends – to measure the effectiveness of interventions  
 Reviews (if a pathway lasts longer than 6 months) – to monitor change and improvement within 
an episode  
 Three months after the episode ends (i.e. 3 months post episode) – to assess outcomes as a result 
of treatment at a service and whether improvements have been maintained.  
The parent impact questionnaire is collected at the start and end of the episode, every 12 months during a 
pathway and 3 months after discharge from the service.  
Patient 
Episode 1 Episode 2 
Group 
program 
Individual 
appointments 
Patient 
Service 
events 
Episode 
Pathway 
G
ro
u
p
 p
ro
gr
am
 –
 
2
0
 h
o
u
rs
 
P
h
ys
io
 1
 h
r 
P
h
ys
io
 1
 h
r 
P
sy
ch
 1
 h
r 
M
e
d
ic
al
 1
 h
r 
A
ss
e
ss
m
e
n
t 
3
 h
rs
 
M
e
d
ic
al
 1
 h
r 
 
Patient outcomes in paediatric pain management, 2020 mid-year report 
61 
Appendix E — Interpreting this report 
Benchmark profile graphs 
The ePPOC benchmarking graphs present results from your service in comparison to all other services 
participating in ePPOC. In each graph, the shaded region describes the Australasian profile for that outcome 
measure. The red line indicates the level at which the benchmark is set. Your service is highlighted as a red 
dot. 
 
 
 The vertical axis shows the % of patients 
experiencing a clinically significant 
improvement 
 The purple region shows the Australasian 
profile for this benchmark. It contains All 
services that contributed to this benchmark, 
ordered from the highest to the lowest % 
 The dot indicates your position relative to the 
benchmark and the other contributing 
services. If there is no red dot on your graph 
this indicates that your service reported less 
than 10 outcomes for this benchmark 
Socioeconomic disadvantage figure 
 
Figure 46 shows the relative socioeconomic disadvantage of your patient population based on residential 
address at referral. The information uses the Socio-Economic Index for Areas – Index of Relative 
Disadvantage, and the New Zealand Index of Relative Socioeconomic Deprivation. These indices group 
residential area into five disadvantage quintiles (from least to most) such that across the national Australian 
and New Zealand populations, 20% of people live in each disadvantage quintile. It’s important to note that 
the level of disadvantage relates to the area the person lives in, not the person themselves.  
 
Figure 46 compares the proportion of your patients who live in each disadvantage group to:  
 the population of all people seeking pain management in Australasia (All services) 
 the expected distribution of disadvantage (Australasian expected %)  
 
Body Mass Index figure 
Table 26 shows Body Mass Index (BMI) information for your patients compared to All services. This uses 
data collected at referral and is presented as the proportion of people who are underweight, healthy 
weight, overweight and obese.  
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